Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-241.23%Free Cash Flow Margin
VS
Market
Sector
Industry
History
$ 1.01Close
$ 0.53 - $ 4.4 52-Week Range
Ticker Information
Ticker
STROCompany Name
SUTRO BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSUTRO BIOPHARMA INC - Free Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
STRO - FCF % Historical data
| Date | Free Cash Flow | Free Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -252.02M | -241.23% | $ 104.47M |
| 3/31/2025 | $ -198.51M | -298.8% | $ 66.43M |
| 12/31/2024 | $ -194.64M | -313.71% | $ 62.04M |
| 9/30/2024 | $ -109.2M | -67.85% | $ 160.96M |
| 6/30/2024 | $ -77.69M | -45.87% | $ 169.36M |
| 3/31/2024 | $ -119.19M | -77.36% | $ 154.06M |
| 12/31/2023 | $ -115.93M | -75.41% | $ 153.73M |
| 9/30/2023 | $ -155.79M | -320.28% | $ 48.64M |
| 6/30/2023 | $ -56.85M | -99.97% | $ 56.87M |
| 3/31/2023 | $ -29.43M | -39.48% | $ 74.55M |
Key Performance Insights, Last 5 Years
- SUTRO BIOPHARMA INC's latest trailing twelve months (TTM) FCF % stands at -152.2%.
- Over the past 5 years, SUTRO BIOPHARMA INC's average FCF % has been -144.91%.
- The median FCF % for SUTRO BIOPHARMA INC during this period was -154.48%
- SUTRO BIOPHARMA INC reached its highest FCF % over the past 5 years at -1.71%.
- The lowest FCF % recorded by SUTRO BIOPHARMA INC in the same timeframe -320.28%
SUTRO BIOPHARMA INC's FCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF % Benchmarks
Similar metrics to Revenues:
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Free Cash Flow Margin
[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.FCF / Revenues
(=) FCF % FCF % for SUTRO BIOPHARMA INC is calculated as follows: FCF [ $ -69.63M ] / Revenues [ $ 45.75M ]
(=) FCF % [ -152.2% ] STRO - Free Cash Flow Margin, Last 5 years
-320.28%
Minimum
Sep 30, 2023
-1.71%
Maximum
Sep 30, 2022
-144.91%
Average
-154.48%
Median
FCF % Benchmark AnalysisMarket
The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.85% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
| filtered constituents | 3.18K |
|---|---|
| min | -58.23% |
| max | 68.19% |
| average | 7.85% |
| median | 7.37% |
| std | 19.48% |